Latest filing published 05 Nov 2025 for Astrana Health, Inc., €316k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Linda Marsh (board member) discloses dealings in 2 companies, chiefly Astrana Health, Inc. and Fulgent Genetics, Inc. The record holds 14 filings, for trades running from 20 May 2021 to 3 November 2025.
The open-market record consists of 1 sale worth €8.8M, with no purchase. Outside the open market, there are 9 share grants and 3 option exercises.
The newest entry dates from 5 November 2025: an option exercise of €316k, in Astrana Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations